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Teratocarcinoma stem cell F9 expressed a potent fucosyltransferase activity acting on asialofetuin. A 
majority of the product was susceptible to cr-L-fucosidase I from almond emulsin, indicating that the 
linkage formed was mainly Fuccul --+ 3GlcNAc. The specific activity of the transferase decreased when 
the stem cells were induced to differentiate into parietal endoderm cells by retinoic acid and dibutyryl cyclic 
AMP. Furthermore, PYS-2 cell, a parietal endoderm cell line virtually lacked the transferase. The change 
in the fucosyltransferase activity could be correlated with cell surface changes occurring during 
differentiation. 
~~YcosyItransferase 
Differentiation 
1. INTRODUCTION 
Cell surface carbohydrates are known to be 
altered in highly ordered manners during early 
stages of mammalian embryogenesis [l-S]. The 
phenomenon probably reflects the importance of 
protein-carbohydrate interactions to accomplish 
the embryogenesis. Being interested in the 
mechanism of the programmed alterations, we 
have initiated studies on glycosyltransferases 
responsible for the cell surface changes. Because of 
the limited av~lability of early embryos, we 
employed a model system, namely the teratocar- 
cinema system, in which the stem cell resembles 
multipotential cells of early embryos and can be in- 
duced to differentiate in vitro [9]. 
2. MATERIALS AND METHODS 
F9 cells [lo] were cultured and induced to dif- 
Abbreviations: Diff-F9, I79 cells differentiated by 
retinoic acid and dibutyryl cyclic AMP; FBP, fucose- 
binding proteins of Lotus tetragonolobus 
Te~tocarcinoma stem cell 
Parietal endoderm cell 
Cell surface 
ferentiate as in 171. PYS-2 cells [l l] were cultured 
as in [ 11. Asialofetuin was prepared by mild acid 
hydrolysis (0.1 M H2S04, 8O*C, 30 min) of fetuin 
(Sigma). Emb~oglycan, the glycoprotein-bound 
large carbohydrates of early embryonic cells 
[ 1,121, was prepared from F9 cells as in [ 123. 
For the measurement of fucosyltranferase activi- 
ty, cells from 2-5 dishes (10 cm, Falcon) were 
homogenized at 4°C with 0.7-1.0 ml of 50 mM 
Tris-maleate buffer (pH 7.0) containing 0.5% 
Triton X-100 and 25 mM MnClz. After ultracen- 
trifugation at 78~ x g for 1 h, 50 ,J of the super- 
natant (or that diluted with the extraction medium) 
was mixed with 10,ul of aqueous solution of 
asialofetuin (50 mg/ml) and 10 pl of aqueous solu- 
tion of GDP-[‘4C]fucose (1.1 x lo5 dpm, 
0.260 nmol, New England Nuclear). The reaction 
was continued at 37°C for 30 min, and stopped 
with 10~1 of 7.5% sodium tetraborate cont~ning 
0.2 M EDTA. The reaction mixture was analyzed 
by gel filtration on a column of Sephadex G-50 
(1.4 x 33 cm), which was equilibrated and eluted 
with 0.05 M ammonium acetate buffer, pH 6.0. 
Radioactivity eluted in the excluded volume was 
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taken as radioactive fucose transferred to the ac- 
ceptor, after subtracting the value obtained in the 
control run in which asialofetuin was omitted from 
the reaction mixture. The values of the control run 
were less than 100 dpm in all cases. The activity 
was roughly proportional to the amount of enzyme 
(fig.1) and reaction time (up to 30 min) provided 
that the amount of the transferred fucose was less 
than 10 pmol. 
For the measurement of nucleotide 
pyrophosphatase, GDP-[‘4C].fucose was incubated 
with the cell extract under the condition described 
above except that asialofetuin was omitted, and 
the products were analyzed by paper 
chromatography in ethylacetate/pyridine/acetic 
acid/Hz0 (5:5: 1:3, by vol.) [13]. Digestion with 
Lu-L-fucosidase I from almond emulsin [14] was 
carried out as in [2]. 
3. RESULTS AND DISCUSSION 
F9 cell is a clonal line of teratocarcinoma stem 
Fucose incorporated (dpm ) 
Fucose incorporated (pm01 )
Fig.1. Activities of the fucosyltransferase from F9 cells 
(o), the cell induced to differentiate into parietal 
endoderm cells (0, Diff-F9 cells) and PYS-2 cells (A). 
The cell extract was prepared and used for the enzyme 
assay as described insection 2. The volume of extraction 
medium used, the number of 10 cm culture dishes used 
to propagate the cells and the protein concentration i
the extracts were as follows: F9 cells, 0.8 ml, 2 dishes, 
3.30 mg/ml; Diff-F9 cells, 0.7 ml, 5 dishes, 1.86 mg/ml; 
PYS-2 cells, 0.7 ml, 2 dishes, 2.80 mg/ml. 
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cell. A potent fucosyltransferase activity was 
detected in Triton extract of the stem cells, using 
asialofetuin as an acceptor (fig.1). When F9 cells 
were induced to differentiate into parietal en- 
doderm cells (Diff-F9 cells) by treating with 
retinoic acid and dibutyryl cyclic AMP [15] for 5 
days, the specific activity of the fucosyltransferase 
decreased to 22% of the original one (fig.1). In 
another experiment performed independently, the 
specific activity decreased to 20%. Considering 
that around 10% of the cells remained mor- 
phologically undifferentiated at the stage examin- 
ed, it is apparent hat differentiation to parietal en- 
doderm cells was accompanied by marked reduc- 
tion in the fucosyltransferase activity. Further- 
more, PYS-2 cell, a clonal line of parietal en- 
doderm cell, was found to virtually lack the 
fucosyltransferase (fig.1). It should be noted that 
the F9 cells and PYS-2 cells were derived from the 
same teratocarcinoma line, namely teratocar- 
cinema OTT6050. 
The decreased activity of the fucosyltransferase 
can be explained not only by the decreased amount 
of the enzyme but also by increased amount of 
nucleotide pyrophosphate or fucosidase. However, 
the transferase activity of F9 cells was not inhibited 
by the extract from PYS-2 cells (table 1) or Diff-F9 
cells (not shown). Furthermore, the level of 
nucleotide pyrophosphate acting on GDP-fucose 
was higher in the extract from F9 cells as compared 
to that from PYS-2 cells (table 1) or from Diff-F9 
Table 1 
Evidence showing that PYS-2 extract did not have 
substances inhibitory for the assay of the 
fucosyltransferase 
Enzyme preparations= Fucose GDP-fucose 
transferred decomposed 
(dpm)b (Q)c 
F9 cells 
PYS-2 cells 
F9 cells + PYS-2 cells 
3714 60 
100 3.6 
3883 - 
a Protein concentration of the extract from F9 cells was 
2.5 mg/ml and that from PYS-2 cells was 2.6 mg/ml 
b The extract (25 ~1) was mixed with the extraction 
medium (25 ~1) or with the extract from the other cell 
(25 ~1) and was used for the assay 
’ Fifty pl of the extract was used 
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cells (26% decomposition by 93 pg protein). These 
results indicate that enhanced destruction of 
substrates or products is not the reason for 
decreased fucosyltransferase activity in parietal en- 
doderm cells. 
So far two fucosyltransferases, namely 
Fuccvl - 2Gal tr.ansferase and Fuccvl - 
3GlcNAc transferase, are known to act on 
asialofetuin, which have Gal&l - 4GlcNAc ter- 
mini [16]; 77% of the fucose transferred to 
asialofetuin by the extract from F9 cells was releas- 
ed by cu-L-fucosidase I from almond emulsin, 
which acts on Fuozl - 3,4GlcNAc linkages but 
not on Fuccvl --+ 2Gal linkage, Fuccrl - 
6GlcNAc linkage 1141 nor on Fucrvl - 3Gal 
linkage (unpublished). Thus, we propose that the 
newly formed fucosyl linkage was mainly Fum1 
- 3GlcNAc. 
The predominant carrier of fucose in plasma 
membrane of F9 cells is embryoglycan, the 
glycoprotein-bound large carbohydrates [ 1,121. 
The extract from F9 cells could transfer fucose not 
only to asialofetuin, but also to embryoglycan, 
which also has unfucosylated GM1 - 4GlcNAc 
termini [12] (fig.2). Thus, the transferase under in- 
& 
rl 
FRACTION UMBER 
Enzymatic transfer of fucose from GDP- 
[“Clfucose to embryoglycan. The reaction was carried 
out as described in section 2 using 160 ag of the enzyme 
protein and SOpg embryoglycan as the acceptor. The 
product was analyzed on a column of Sephadex G-50 
(1.8 x 91 cm) equilibrated and eluted with 0.05 M 
ammonium acetate buffer, pH 6.0. Fractions, 3 ml were 
collected. Vo and Gal represent the area where blue 
dextran or galactose was eluted. (M) Experimental 
run; (O---O) control run in which embryoglycan was 
not added to the reaction mixture. 
vestigation is involved in formation of cell surface 
structures of F9 cells. 
Differentiation to parietal endoderm cells ac- 
companies drastic alteration in cell surface. 
Notably, receptors for fucose binding proteins of 
Lotus tetragonolobus (FBP) and SSEA-1 defined 
by a monoclonal antibody are present in the stem 
cells but are absent in parietal endoderm cells 
[3,17]. SSEA-1 is a carbohydrate antigen determin- 
ed by Fuccvl - 3GlcNAc linkage [15]. Evidence 
accumulating in our laboratory [2,8,12] suggests 
that in the stem cells, the major binding site for 
FBP is also in the form of the Fuccul - 3GlcNAc 
linkage. Thus, the decreased activity of the 
fucosyltransferase can be correlated with the 
disappearance of the cell surface marker(s) from 
the differentiated cells. In other words, the 
differentiation-dependent alterations of cell sur- 
face [3,17] appear to be caused not only by the sup- 
pression of synthesis of embryoglycan [7], an en- 
dogenous acceptor for the fucosyltransferase, but 
also by suppression of the fucosyltransferase itself. 
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